AI in Protein Design: Hype vs. Reality Explained by David Baker
In an interview with GEN, Nobel Laureate David Baker, PhD, director of the Institute for Protein Design at the University of Washington, reflected on the current state of AI-driven protein design and what’s still needed for the field to deliver on its medical promise.
Baker, who shared the 2024 Nobel Prize in Chemistry for developing computational tools to design novel proteins, discussed both the potential and limitations of artificial intelligence in creating new proteins for pharmaceuticals, vaccines, nanomaterials, biosensors, and more. His insights highlighted the balance between scientific enthusiasm and the practical challenges of bringing AI-designed proteins into real-world applications.
The conversation underscores Seattle’s central role in advancing the intersection of artificial intelligence and protein design, reinforcing the region’s global leadership in life science innovation.